These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20399366)

  • 1. DVT prophylaxis in total joint reconstruction.
    Sheth NP; Lieberman JR; Della Valle CJ
    Orthop Clin North Am; 2010 Apr; 41(2):273-80. PubMed ID: 20399366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for thromboprophylaxis in lower joint arthroplasty.
    Colwell CW
    Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
    Colwell CW
    Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations.
    Miric A; Lombardi P; Sculco TP
    Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in DVT prophylaxis and management in major orthopaedic surgery.
    Hardwick ME; Colwell CW
    Surg Technol Int; 2004; 12():265-8. PubMed ID: 15455336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin.
    Berend KR; Lombardi AV
    Am J Orthop (Belle Mead NJ); 2006 Jan; 35(1):24-9. PubMed ID: 16475420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
    Garcia-Zozaya I
    J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.
    Lachiewicz PF
    Orthopedics; 2009 Dec; 32(12 Suppl):74-8. PubMed ID: 20201480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty.
    Callaghan JJ; Warth LC; Hoballah JJ; Liu SS; Wells CW
    J Arthroplasty; 2008 Sep; 23(6 Suppl 1):20-4. PubMed ID: 18722299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.